Results 131 to 140 of about 222,790 (315)
, 2011 PhDThis thesis is concerned with the development of incentives for pharmaceutical R&D, specifically for neglected diseases. The following approaches are adopted.
Trushin, Eshref
core
Nanomaterial Integration at Liquid–Liquid Interfaces for Green Catalysis
Advanced Materials, EarlyView.Functional nanomaterials assembled at liquid–liquid interfaces create dual‐role platforms serving as emulsion stabilizers and catalytic sites, offering enhanced reaction kinetics with improved catalyst recovery and recyclability. This review examines design strategies, structure‐performance relationships, and industrial implementation prospects of ...
Bokgi Seo +6 more
wiley +1 more source
The Pharmaceutical Industry in Australia
, 2007 This paper is concerned with describing and explaining some key structural characteristics of Australian pharmaceutical markets and their associated supply chains.
Sweeny, Kim
core
Thiolated Polymers in 3D Bioprinting: Control of Gelation
Advanced Materials, EarlyView.Thiolated polymers are established as programmable bioinks for 3D bioprinting, integrating versatile crosslinking chemistries with redox‐responsive control. This work demonstrates how molecular design and external triggers define gelation kinetics, printability windows, and structural fidelity, enabling stable, high‐resolution constructs and advancing ...
Soheil Haddadzadegan +2 more
wiley +1 more source
The Cost of US Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions [PDF]
Previous empirical studies that have examined the links between pharmaceutical price controls, profits, cash flows, and investment in research and development (R&D) have been largely based on retrospective statistical analyses of firm- and/or industry ...
John A. Vernon, Thomas A. Abbott
core
Lead Halide Perovskite Photoelectrocatalysis
Advanced Materials, EarlyView.Lead halide perovskite semiconductors have emerged as highly promising materials for solar fuel and chemical synthesis. This perspective discusses advances made in the rational photoelectrode design to improve solar‐to‐chemical conversion, product scope, and scalability.
Virgil Andrei
wiley +1 more source
Inter-firm R&D networks in the global pharmaceutical biotechnology industry during 1985 - 1998: A conceptual and empirical analysis [PDF]
This paper analyses a large database on inter-firm R&D cooperation formed in the pharmaceutical biotechnology industry during the period 1985 - 1998. The results indicate that network size largely grows, whereas the density of the network declines during
Schwalbe, Ulrich, Krogmann, Yin
core
Advanced Materials Interfaces, EarlyView.Chitosan–TiO2 composite hydrogels combine adsorption of organic pollutants with photocatalysis, allowing to remove 85% of a broadly diffused antibiotic (sulfamethoxazole) under direct sunlight irradiation, opening great promises for point‐of‐use, outdoor applications.
Beatrice Cerea +5 more
wiley +1 more source
International pharmaceutical price differences [PDF]
The study compares manufacturer prices in Australia and seven other countries for 150 pharmaceuticals listed on the Pharmaceutical Benefits Scheme (PBS), as at 30 June 2000.
Productivity Commission
core
Interface‐Engineered Binary Framework Composites: Advancing Porous Materials for Precision Medicine
Advanced Materials Interfaces, EarlyView.Binary framework composites integrate two complementary porous architectures into a unified platform, enabling multifunctional design, enhanced structural tunability, and improved physicochemical performance. By combining high surface area, ordered porosity, interfacial synergy, and versatile functionalization, these hybrid materials offer new ...
Navid Rabiee +3 more
wiley +1 more source